I IFN- armen blev patienterne behandlet med en måldosis IFN på 5 MIE/ m2/ dag subkutant i kombination med subkutant Ara- C 20 mg/ m2/ dag i 10 dage/ måned.
In the IFN arm, patients were treated with a target dose of IFN of 5 MIU/ m2/ day subcutaneously in combination with subcutaneous Ara-C 20 mg/ m2/ day for 10 days/ month.